Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000558041 | SCV000656040 | benign | Dyskeratosis congenita, autosomal dominant 6 | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001821640 | SCV002064750 | benign | not specified | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000558041 | SCV002524364 | benign | Dyskeratosis congenita, autosomal dominant 6 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV001821640 | SCV002551710 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002330969 | SCV002634425 | likely benign | Inborn genetic diseases | 2021-06-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004710137 | SCV005249240 | benign | not provided | criteria provided, single submitter | not provided |